Particle Therapy Sparks Social Innovations for Improving Cancer Patient Outcomes
Particle therapy is also known as the radiation therapy that uses streams of protons that are tiny particles with a positive charge to kill tumor cells. Healthcare providers are increasingly making available different types of particle therapy for cancers such as heavy ion therapy and proton therapy (PT). Non-invasive nature and reduced side effects of proton therapy systems are being preferred for the treatment of bladder cancer in patients.
In order to increase patient outcomes, companies in the particle therapy market are turning challenging collaboration projects and concepts into solutions that serve social innovation. Leading research and care institutes are joining forces to advance in innovations for radiotherapy. Technological developments in cyclotron machines are one of the important strategies that are underway for the treatment of cancer patient.
Request Sample of Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=56133
Cancer Care Centers Adapting to Rigid Safety Protocols amid COVID-19 Pandemic
The COVID-19 pandemic has potentially slowed the progress of paradigm-changing innovations in particle that could improve the lives of future generations. Nevertheless, companies in the particle therapy market are adapting to the new normal by continuing care services for high-risk and vulnerable cancer patients.
Cancer care facilities are implementing rigid safety protocols and adaptations for the patients & staff. In order to ensure the adherence to safety protocols, cancer care centers are instituting many precautions that include daily screenings of every staff member, patient, and visitor to the center. In addition, rise of telemedicine and remote patient monitoring would likely become one of the defining influences of the pandemic on the global healthcare industry.
High Cost and Technological Challenges Inhibiting Growth of Particle Therapy Market
The global particle therapy market is projected to advance at a robust CAGR throughout the assessment period. However, lack of evidence about clinical outcomes, high cost of therapy, and radiobiological uncertainties are hampering its widespread adoption among cancer patients. Hence, companies in the particle therapy market are increasing R&D to overcome technological challenges and increasing efforts to integrate technical developments into particle therapy systems.
Companies in the particle therapy market are conducting research studies to continuously improve the efficiency of proton therapy systems, in terms of technology and delivery technics & cost. Significant developments are being made in terms of conformation of the dose to the target and transport & spatial resolution achievable with pencil beam scanning.
Request for Covid-19 Impact Analysis –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=56133
Different Cancer Types Fueling Demand for Proton Therapy
There is a growing demand for proton therapy for the treatment of breast cancer, brain tumor, and pediatric cancer. There is a high prevalence of inflammatory breast cancer, triple negative breast cancer, and invasive ductal carcinoma breast cancer globally.
The proton therapy is also being used in the treatment of patients with benign tumors, tumors near sensitive areas of the brain, and patients who have recurrent brain tumors following treatment.
In addition, advantages of photon-beam radiotherapy are being extended for the treatment of pediatric cancer, since this treatment method is found to limit the radiation exposure to healthy and growing tissue in children, adolescents, and young adults.
Lucrative Market Expansion Opportunities in India and Italy
An alarmingly high number of cancer cases in India and Italy have compelled healthcare companies in the particle therapy market to invest in state-of-the-art facilities. These facilities are accommodating the hadron therapy, as a part of their care services profile.
The possibility to treat radio-resistant tumors, precision treatment, and suitability for the treatment of brain, skull, and spinal cord is increasing the popularity of hadron therapy among patients. Head, neck, and upper respiratory tract tumors are being treated with the help of the hadron therapy.
Request for Custom Research –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=56133
Particle Therapy Market: Overview
- Increase in adoption of particle therapy along with advantages such as high precision, shorter treatment duration, and lower side-effects compared to conventional photon therapies using X-rays are expected to drive the global particle therapy market from 2022 to 2031
- Surge in investment in cancer research is likely to fuel the growth of the particle therapy market during the forecast period. Moreover, rise in adoption of various particle therapy products by hospitals and clinics is projected to propel the global market from 2022 to 2031.
Rise in Adoption of Particle Therapy in Clinical Trials to Drive Global Market
- Interest in proton beam therapy (PBT) has increased in the past few years. The physical properties of charged particle therapy enable superior dose distribution. Hence, PBT offers potential opportunities to reduce toxicity and increase tumor control. The number of cancer surgical procedures has increased in the past few years. Hence, the adoption rate of particle therapy is rising to treat the after effects of cancer surgery.
Increase in Application of Proton Therapy to Treat Cancer
- The proton therapysegment held major share of the global market in terms of revenue in 2021. The segment is anticipated to reach US$ 1,063.0 Mn by 2031. Increase in applications of proton therapy to treat several cancers such as brain tumor, breast cancer, pediatric cancer, head and neck cancer, and other noncancerous tumors is expected to drive global particle therapy market during forecast period. Due to the unique physical properties of protons, doctors are able to deliver radiation to a specific depth in the body. Hence, proton therapy is more effective than heavy ion therapy.
- Presently, proton therapyis used to treat different types of cancer, and it is especially useful in situations where treatment options are limited and conventional photon-beam radiotherapy poses unacceptable risks to patients. It is also useful when treating brain and spinal cord tumors in children, who frequently suffer long-term side effects from toxic cancer treatments.
Enquiry Before Buying –
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=56133
Brain & Spinal Cord Tumors (BSCT) Segment to Lead Global Particle Therapy Market
- The brain & spinal cord segment was valued at US$ 117 Mn in 2021 and is set to expand at the fastest CAGR from 2022 to 2031
- Particle therapy is primarily used to treat head & neck cancer and pediatric cancers. It is also used to treat spine tumors, breast cancer, sarcoma, brain tumors, and prostate cancer. The brain & spinal cord tumors (BSCT) segment is expected to account for major share of the global particle therapy market during the forecast period. Limiting radiation doses to other critical structures such as the brain stem, spinal cord, and healthy brain tissue that control important body functions is critical when treating brain & other central nervous system cancers.
- Advantages over non-small cell lung cancer (NSCLC) treatment and rise in awareness about the use of particle therapy for lung cancer treatment are likely to propel the segment during the forecast period.
Rise in Use of Cyclotrons
- The cyclotronssegment is projected to drive the global particle therapy market from 2022 to 2031. The cyclotrons segment accounted for the largest share of 60% of the global market in 2021.
- A cyclotron is an important piece of technology for proton therapy, which uses an aimed beam of protons directed at a tumor site to treat various cancers. Proton beam therapy uses specialized machines, the most common of which are cyclotrons, to generate and accelerate protons to speeds of up to 60% the speed of light and energies of up to 250 million electron volts.
Hospitals Segment to Lead Global Particle Therapy Market
- The hospitalssegment led the global particle therapy market in 2021. The segment is anticipated to account for 67.9% share of the market by 2031. The hospitals segment is expected to expand at a CAGR of 9.0% from 2022 to 2031.
- Proton therapy is available in several hospital-based facilities, many of which are built and supported by commercial vendors
North America to Dominate Global Particle Therapy Market
- North America dominated the global particle therapy market in 2021. The market in the region is anticipated to expand at a CAGR of 7.6% from 2022 to 2031. Growth of the market in North America can be attributed to early adoption of innovative medicated treatment and availability of larger number of particle therapy centers.
- According to the National Association for Proton Therapy, proton therapy is the most frequently used particle therapy in the U.S., and over 75,000 patients have been treated with proton therapy. Moreover, the U.S. has 38 centers providing proton therapy. Hence, North America is expected to account for major share of the global market during the forecast period.
- Europe is expected to be the fastest growing market for particle therapy from 2022 to 2031. Availability of technologically advanced platforms for the diagnosis of disorders, increase in incidence of cancer, large number of distribution channels, and launch of innovative & advanced technologies by major manufacturers are likely to augment the market in the region during the forecast period. Germany dominated the market in Europe in 2021. The market in Germany is projected to grow at a rapid pace from 2022 to 2031.
- Asia Pacific is one of the leading markets for particle therapy due to rise in prevalence of cancer and increase in number of radiotherapy procedures
Major Players in Particle Therapy Market
- The particle therapy market report concludes with the company profiles section, which includes key information about major players in the global particle therapy market
- Leading players analyzed in the report include
- Advanced Oncotherapy plc
- Danfysik A/S
- Hitachi, Ltd.
- IBA Worldwide
- Mevion Medical Systems, Inc.
- Optivus Proton Therapy, Inc.
- ProTom International, Inc.
- Provision Healthcare
- Sumitomo Heavy Industries, Ltd.
- Varian Medical Systems, Inc
- Other prominent players
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
0
